Abstract:Background. Oxidative stress has a vital role in the early stages of vitiligo. Autoantigens released from apoptotic melanocytes (MC) under oxidative stress are involved in the presentation and recognition of antigens. However, the transport of autoantigens to the cell surface and their release to the extracellular environment are still unclear. Apoptotic bodies (ABs) have always been considered as a key source of immunomodulators and autoantigens. Yet, the role of ABs in the immune mechanism of vitiligo is still unknown. Purpose. To explore whether MC’s autoantigens translocate into ABs during oxidative stress-induced apoptosis and study the molecular mechanisms underlying autoantigen migration and AB formation. Methods. PIG3V (an immortalized human vitiligo melanocyte cell line) were treated with H2O2, and ABs were separated. Transmission electron microscopy, flow cytometry, Western blot, mass spectrometry, and other methods were used to determine the relocation of specific antigens in PIG3V cells to ABs. After pretreatment with specific inhibitors (Rho kinase (Y-27632), myosin light chain kinase (MLCK, ML-9), pan-caspase (zVAD-FMK), and JNK (SP600125)), the pathway of autoantigen translocation into ABs and the formation of apoptotic bodies were determined. Results. When treated with 0.8 mM H2O2, ABs were released from these cells. Autoantigens such as tyrosinase-related protein 1 (TYRP-1) and cleavage nuclear membrane antigen Lamin A/C (Asp230) were concentrated in ABs. The expression of autoantigens and the formation of ABs increased in a time- and dose-dependent manner after treatment with H2O2, while the application of specific inhibitors inhibited the formation of apoptotic bodies, i.e., the expression of antigens. Conclusion. Vitiligo autoantigens translocate into ABs in the process of apoptosis induced by oxidative stress. The cytoskeletal protein activation pathway and the JNK-related apoptosis pathway are involved in the transport of autoantigens and the formation of ABs. ABs may be the key bridge between MC cell apoptosis and cellular immunity.

The fate of melanocyte: Mechanisms of cell death in vitiligo

Mechanisms of melanocyte death in vitiligo

Oxeiptosis: a novel pathway of melanocytes death in response to oxidative stress in vitiligo

The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death

RIP1-Mediated Necroptosis Facilitates Oxidative Stress‒Induced Melanocyte Death, Offering Insight into Vitiligo

1268 Necroptosis is a Novel Way of Melanocyte Death in Oxidative-Related Vitiligo Pathogenesis

DCUN1D1, a new molecule involved in depigmentation via upregulating CXCL10

The Formation of Melanocyte Apoptotic Bodies in Vitiligo and the Relocation of Vitiligo Autoantigens under Oxidative Stress

Melanocyte-keratinocyte cross-talk in vitiligo

Increased Splicing of CXCR3 Isoform B (CXCR3B) by Impaired NRF2 Signaling Leads to Melanocyte Apoptosis in Active Vitiligo

Mechanism of CD8+T cells killing melanocytes in the patients with vitiligo

Intracellular virus sensor MDA5 exacerbates vitiligo by inducing the secretion of chemokines in keratinocytes under virus invasion

Mesenchymal Stem Cells Promote Human Melanocytes Proliferation and Resistance to Apoptosis Through PTEN Pathway in Vitiligo

Suppression of FADS1 Induces ROS Generation, Cell Cycle Arrest, and Apoptosis in Melanocytes: Implications for Vitiligo

Loss of 'Epidermal Melanin Unit' Integrity in Human Skin During Melanoma-Genesis

Oxidative stress-induced hypermethylation and low expression of ANXA2R: novel insights into the dysfunction of melanocytes in vitiligo

Vitiligo: A focus on pathogenesis and its therapeutic implications

Homocysteine Induces Melanocytes Apoptosis Via PERK–eIF2α–CHOP Pathway in Vitiligo

Vitiligo: Mechanisms of Pathogenesis and Treatment

HSF1-Dependent Autophagy Activation Contributes to the Survival of Melanocytes Under Oxidative Stress in Vitiligo

Clinical Features, Immunopathogenesis, and Therapeutic Strategies in Vitiligo